IsoRay Inc. (ISR) Archives - Smallcaps Investment Research

News » IsoRay Inc. (ISR)

IsoRay Stock Price Hammered After… Excellent Study Results

May 30, 2015 Leave a comment

IsoRay, Inc. (ISR – $1.80), our favorite medical technology Company, is an innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head, neck and gynecological cancers. Its various products, including Cesium-131 seeds, sutured seeds, stranded mesh and the GliaSite radiation therapy system, give physicians the ability to directly place a specified dosage of radiation […]

IsoRay Inc. (ISR)

IsoRay Continues To Make Waves In Cancer Treatment Market

March 14, 2015 Leave a comment

IsoRay, Inc. (ISR – $1.57), our favorite medical technology Company, is an innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head, neck and gynecological cancers. IsoRay is the exclusive manufacturer of Cesium-131, which allows for the precise treatment of many different cancers thanks to its unrivaled blend of high energy and its 9.7 […]

IsoRay Inc. (ISR)

96% of Patients Experience NO Recurrence of Brain Cancer After IsoRay Treatment

December 6, 2014 Leave a comment

IsoRay, Inc. (ISR – $1.76), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of cancers of the prostate, brain, lung, head and neck and gynecological, announced exceptional results conducted by researchers at the Barrow Neurological Institute, one of the world’s foremost brain cancer research and treatment sites. The Barrow study reported on […]

IsoRay Inc. (ISR)

Small Cap Updates & New Recommendations – April 5, 2014

April 5, 2014 Leave a comment

This week we have updates on Enterprise Group (E), Global Minerals (CTG) and IsoRay (ISR). Enterprise Group (E – $1.02), a consolidator of construction services companies operating in the energy, utility and transportation infrastructure industries, announced strong financial results for its fiscal year 2013. Revenues for 2013 reached $34.8 million, an increase of $16.3 million or 88%, compared with fiscal […]

IsoRay Stock Price Through the Roof

March 22, 2014 Leave a comment

IsoRay Inc’s (ISR – $2.42) stock price went through the roof this week as it announced the world’s first successfully completed pediatric implant using IsoRay Medical’s Cesium-131 brachytherapy mesh. We first featured IsoRay on Smallcaps Investment Research two months ago at 75 cents because we felt that a company with such a valuable technology and an FDA approved product was […]

IsoRay Inc. (ISR)

Updates & New Stocks – February 1, 2014

February 1, 2014 Leave a comment

This week we have updates on Oroco Resource Corp (OCO), Goldgroup Mining (GGA), IsoRay Inc. (ISR) and we introduce a new company called LiqTech International (LIQT) which develops clean air and water technologies. Goldgroup Mining (GGA – $0.17) produced an initial 285 ounces of gold from its Cerro Prieto heap-leach mine located in Sonora, Mexico. Keith Piggott, Chairman, President & […]

Updates & New Stocks – January 25, 2014

January 25, 2014 Leave a comment

This week we have updates on Global Minerals (CTG) and Enterprise Group (E) and we introduce an exciting new small cap stock called IsoRay Inc. (ISR) As we wrote last week, good reputations still go a long way. Despite tough market conditions for commodities companies, Global Minerals (CTG – $0.05) will most likely be able to raise more than the […]